125 related articles for article (PubMed ID: 19910179)
1. Two novel mutations in surfactant protein-C, lung function and obstructive lung disease.
Baekvad-Hansen M; Nordestgaard BG; Tybjaerg-Hansen A; Dahl M
Respir Med; 2010 Mar; 104(3):418-25. PubMed ID: 19910179
[TBL] [Abstract][Full Text] [Related]
2. Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion.
Dahl M; Nordestgaard BG; Lange P; Tybjaerg-Hansen A
J Allergy Clin Immunol; 2001 May; 107(5):818-23. PubMed ID: 11344348
[TBL] [Abstract][Full Text] [Related]
3. Genetic and biochemical markers of obstructive lung disease in the general population.
Dahl M
Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
[TBL] [Abstract][Full Text] [Related]
4. [Genetic basis in chronic interstitial familial pneumopathy. Familial study of SFTPC].
Somaschini M; Cavazza A; Riva S; Sassi I; Carrera P
Pediatr Med Chir; 2005; 27(3-4):103-7. PubMed ID: 16910460
[TBL] [Abstract][Full Text] [Related]
5. Inherited disorders of neonatal lung diseases.
Yurdakök M
Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
[TBL] [Abstract][Full Text] [Related]
6. New surfactant protein C gene mutations associated with diffuse lung disease.
Guillot L; Epaud R; Thouvenin G; Jonard L; Mohsni A; Couderc R; Counil F; de Blic J; Taam RA; Le Bourgeois M; Reix P; Flamein F; Clement A; Feldmann D
J Med Genet; 2009 Jul; 46(7):490-4. PubMed ID: 19443464
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
[TBL] [Abstract][Full Text] [Related]
8. β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.
Thomsen M; Nordestgaard BG; Sethi AA; Tybjærg-Hansen A; Dahl M
Eur Respir J; 2012 Mar; 39(3):558-66. PubMed ID: 22075484
[TBL] [Abstract][Full Text] [Related]
9. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort.
van Moorsel CH; van Oosterhout MF; Barlo NP; de Jong PA; van der Vis JJ; Ruven HJ; van Es HW; van den Bosch JM; Grutters JC
Am J Respir Crit Care Med; 2010 Dec; 182(11):1419-25. PubMed ID: 20656946
[TBL] [Abstract][Full Text] [Related]
10. Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals.
Bækvad-Hansen M; Nordestgaard BG; Dahl M
Eur Respir J; 2011 Apr; 37(4):791-9. PubMed ID: 20693256
[TBL] [Abstract][Full Text] [Related]
11. [Polymorphic variants of a surfactant protein C gene in patients with chronic obstructive pulmonary disease].
Tsvetkova OA; Veselovskaia MV
Ter Arkh; 2007; 79(9):65-9. PubMed ID: 18038590
[TBL] [Abstract][Full Text] [Related]
12. Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias.
Markart P; Ruppert C; Wygrecka M; Schmidt R; Korfei M; Harbach H; Theruvath I; Pison U; Seeger W; Guenther A; Witt H
Eur Respir J; 2007 Jan; 29(1):134-7. PubMed ID: 17005585
[TBL] [Abstract][Full Text] [Related]
13. NOD2/CARD15 genotype, cardiovascular disease and cancer in 43,600 individuals from the general population.
Yazdanyar S; Nordestgaard BG
J Intern Med; 2010 Aug; 268(2):162-70. PubMed ID: 20412372
[TBL] [Abstract][Full Text] [Related]
14. Haplotypes of surfactant protein C are associated with common paediatric lung diseases.
Puthothu B; Krueger M; Heinze J; Forster J; Heinzmann A
Pediatr Allergy Immunol; 2006 Dec; 17(8):572-7. PubMed ID: 17121584
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in the scavenger receptor MARCO and its association with chronic obstructive pulmonary disease and lung infection in 10,604 individuals.
Thomsen M; Nordestgaard BG; Kobzik L; Dahl M
Respiration; 2013; 85(2):144-53. PubMed ID: 23154236
[TBL] [Abstract][Full Text] [Related]
16. Elevated ACE activity is not associated with asthma, COPD, and COPD co-morbidity.
Lee J; Nordestgaard BG; Dahl M
Respir Med; 2009 Sep; 103(9):1286-92. PubMed ID: 19423314
[TBL] [Abstract][Full Text] [Related]
17. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation.
Bullard JE; Nogee LM
Pediatr Res; 2007 Aug; 62(2):176-9. PubMed ID: 17597647
[TBL] [Abstract][Full Text] [Related]
18. Heterozygosity for E292V in ABCA3, lung function and COPD in 64,000 individuals.
Bækvad-Hansen M; Nordestgaard BG; Dahl M
Respir Res; 2012 Aug; 13(1):67. PubMed ID: 22866751
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
20. Loss-of-function mutations in the filaggrin gene: no contribution to disease susceptibility, but to autoantibody formation against citrullinated peptides in early rheumatoid arthritis.
Hüffmeier U; Böiers U; Lascorz J; Reis A; Burkhardt H
Ann Rheum Dis; 2008 Jan; 67(1):131-3. PubMed ID: 17704064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
